Dianthus Therapeutics, Inc. /DE/ (DNTH) › Shareholders' EquityDianthus Therapeutics, Inc. /DE/ (DNTH) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$289.0K2016: -$8.87M2017: -$42.12M2018: $145.65M2019: $141.19M2020: $143.91M2021: -$17.25M2022: -$44.37M2023: $168.87M2024: $352.48M2025: $493.40M$493.40M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$493.40M+40.0%2024$352.48M+108.7%2023$168.87M+480.6%2022-$44.37M-157.2%2021-$17.25M-112.0%2020$143.91M+1.9%2019$141.19M-3.1%2018$145.65M+445.8%2017-$42.12M-374.6%2016-$8.87M-2970.6%2015-$289.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share